Pfizer

15 For ’19: Key Clinical Data To Watch For Next Year (Part 1)
Xconomy
Mon, 12/17/18 - 09:44 am
clinical trials
Alzheimer's disease
Biogen
Duchenne Muscular Dystrophy
Pfizer
Solid Biosciences
Sarepta Therapeutics
hemophilia A
Biomarin
Multiple Myeloma
Celgene
Bluebird Bio
Amgen
solid tumors
Bristol-Myers Squibb
Nektar Therapeutics
age-related macular degeneration
Regenxbio
SAGE Therapeutics
MorphoSys
Pfizer Initiates Ph III Trials for Invasive Pneumococcal Disease and Pneumonia Vaccine
CP Wire
Fri, 12/14/18 - 09:42 am
Pfizer
vaccines
pneumococcal disease
pneumonia
20VPnC
Pfizer Initiates Ph III Trials for Invasive Pneumococcal Disease and Pneumonia Vaccine
Fri, 12/14/18 - 09:10 am
Pfizer
20VPnC
vaccines
pneumococcal disease
pneumonia
Senator to Pfizer CEO: Stop playing 'political games' with drug prices
Fierce Pharma
Wed, 12/12/18 - 06:36 pm
Pfizer
drug pricing
Pfizer to add 100 oncology R&D jobs, cut others amid restructure
Biopharma Dive
Wed, 12/12/18 - 12:09 am
Pfizer
layoffs
hirings
R&D
oncology
Lessons From The Biggest Pharma Drug Launches Of All Time
Forbes
Tue, 12/11/18 - 10:26 am
drug launches
Gilead Sciences
JNJ
Pfizer
FDA Flags Pfizer’s Hospira Plant in Kansas Over Repeat 483 Citations
RAPS.org
Sat, 12/8/18 - 10:32 am
FDA
Pfizer
drug manufacturing
Hospira
Biosimilar makers back Pfizer in call to end misleading brand marketing
BioCentury
Tue, 12/4/18 - 11:39 pm
FDA
Pfizer
biosimilars
Pfizer strikes deal with Chinese online pharmacy Jianke
Pharmaforum
Mon, 12/3/18 - 05:53 pm
Pfizer
China
Jianke
AbbVie inks Humira patent deal No. 7, delaying Pfizer's U.S. biosim launch until late 2023
Fierce Pharma
Fri, 11/30/18 - 12:36 pm
AbbVie
biosimilars
Pfizer
Humira
patents
Pfizer wins blockbuster Lyrica patent extension to safeguard sales till June
Fierce Pharma
Wed, 11/28/18 - 11:56 am
Pfizer
Lyrica
patents
FDA
pediatric exclusivity
Playing a hot hand in cancer R&D, Pfizer scores its 4th drug approval in just 2 months
Endpoints
Sat, 11/24/18 - 01:30 pm
Pfizer
FDA
glasdegib
acute myeloid leukemia
AML
Pfizer wants to reel back contributions to Hyde-Smith after her remarks about ‘public hanging’ spark controversy
Endpoints
Wed, 11/21/18 - 10:05 am
Pfizer
campaign donations
politics
Roche yanks Tecentriq kidney cancer applications as Merck, Pfizer speed toward approvals
Fierce Pharma
Tue, 11/20/18 - 12:15 pm
Roche
Merck
Pfizer
Tecentriq
kidney cancer
Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years
BioSpace
Mon, 11/19/18 - 11:29 am
cancer
breast cancer
lung cancer
drug approvals
AstraZeneca
Takeda
Ariad Pharmaceuticals
Merck
Pfizer
Novartis
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Puma Biotechnology
Mylan
Genentech
Merck KGaA and Pfizer say drug failed to meet primary endpoints in late-stage ovarian cancer trial
Marketwatch
Mon, 11/19/18 - 09:59 am
Merck KGaA
Pfizer
avelumab
ovarian cancer
clinical trials
Where Will Pfizer Inc. Be in 5 Years?
Motley Fool
Sun, 11/18/18 - 12:51 pm
Pfizer
Pfizer tests Trump with plans to hike prices on 41 drugs
Biopharma Dive
Fri, 11/16/18 - 08:31 pm
Pfizer
drug pricing
Immunicum Announces Collaboration with Merck KGaA and Pfizer to Evaluate Cell Therapy Treatment in Combination with Avelumab
CP Wire
Fri, 11/16/18 - 10:10 am
Immunicum
immuno-oncology
Merck KGaA
Pfizer
avelumab
Pfizer falls short in U.K. patent appeal for blockbuster Lyrica
Fierce Pharma
Thu, 11/15/18 - 11:12 am
Pfizer
patents
UK
Lyrica

Pages